Global Hydrogel-Based Drug Delivery System Market is estimated to be valued at US$ 4,785.4 Mn in 2022 and is expected to exhibit a CAGR of 6.9% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
There are several therapeutic applications for Hydrogel-Based Drug Delivery Systems, including cardiac illness, inflammatory diseases, and cancer. These devices also have promising applications in the treatment of diabetic foot ulcers. Hydrogels are biodegradable and able to absorb a wide range of drug molecules. The biocompatibility and controlled-release mechanism of this drug delivery system have made them a popular choice for many applications, from pain relief to anti-inflammation treatments. In addition to its biodegradability, hydrogels can be used as drug delivery systems for cancer treatment, such as COVID-19 vaccines.
Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables& Figures, Chart) @ https://www.coherentmarketinsights.com/insight/request-pdf/5022
Key players operating in the market are engaged in business development strategies such as merger, acquisition, and collaboration for the development of new drug delivery systems, which in turn, is expected to drive the market growth. For instance, in December 2018, Neurelis, Inc., a neuroscience company, acquired Aegis Therapeutics, a San Diego-based drug delivery technology company. The company’s proprietary portfolio consists of Hydrogel, Intravail, and ProTek, these are 3 non-invasive drug delivery which can be used for a wide range of peptides, therapeutic proteins, and non-peptide macromolecules.
Global Hydrogel-Based Drug Delivery System Market– Impact of Coronavirus (COVID-19) Pandemic
In the midst of COVID-19 pandemic, tremendous efforts are made for the development of efficient ways for prevention and treatment of COVID-19 caused by SARS-CoV-2. According to a research study published pubmed in April 2021, efficient delivery of drugs to the lung is a significant challenge, hence extensive research is taking place in the area of development of new drug delivery.
Moreover, according to a research study conducted by researchers from Stanford University, proves that slow delivery of antigens with the application of hydrogel can result in a more potent immune reaction. According to the same source, the mice vaccinated with the hydrogel system showed higher immunoglobulin G (IgG) titers, subsequently, stronger immune response across the board than the control vaccinations. Hence, the high research and development for the application of hydrogel-based drug delivery systems in delivering COVID-19 therapeutics is expected to drive the market growth over the forecast period.
Click Here to Get a Sample Copy (Exclusive Offer: Up to 30% Discount for A Limited Time) @ https://www.coherentmarketinsights.com/insight/request-sample/5022
The increasing application of hydrogel for the delivery of tumor treatment drugs is further driving the market growth. The delivery of candidate compounds for tumor treatment may have many problems associated such as low bioavailability, greater toxicity, strong hydrophobicity, and instability. According to a study published Informa UK Limited in March 2020, researchers from China developed In-situ hydrogels for improving bioavailability and limiting the side effects of anti-tumor drugs.
Key Takeaways of the Global Hydrogel-Based Drug Delivery System Market:
- Among regions, Asia-Pacific is expected to have the highest growth rate in the global hydrogel-based drug delivery system market over the forecast period, owing to increasing adoption of hydrogel-based systems for efficient drug delivery processes. For instance, in September 2021, researchers from the National Institute of Immunology (NII) and the Regional Centre for Biotechnology (RCB), India, developed a hydrogel-based delivery system that entrapped first-line anti-tuberculosis (TB) drugs namely Rifampicin, Pyrazinamide, Isoniazid, and Ethambutol. This delivery system helped in the prolonged drug delivery for up to 15 days in mice.
- Major players operating in the global hydrogel-based drug delivery system market include Johnson & Johnson, Bausch & Lomb, Ocular Therapeutix, Inc, Tolmar Pharmaceuticals, Inc., Ashland, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Micropore Technologies, Neurelis, Inc., and ProLynx Inc.
Grab the Offer Mentioned Above Global Outlook and Forecast 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/5022
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Route of Delivery
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key developments
- Regulatory Scenario
- Market Trends
- New Product Launches
- Acquisitions and Agreements
- Brand Analysis
- Regulatory Scenario
- PORTER’s Five Forces Analysis
- Market Dynamics
- Global Hydrogel-Based Drug Delivery System Market – Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact on Healthcare
- Impact on Hydrogel-based Drug Delivery System Manufacturing and Its Market Demand
- COVID-19 Epidemiology
- Global Hydrogel-Based Drug Delivery System Market, By Source, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Natural
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
- Global Hydrogel-Based Drug Delivery System Market, By Route of Delivery, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Oral Cavity
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/hydrogel-based-drug-delivery-system-market-4297
About Coherent Market Insights:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837